BIOFRONTERA INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+36.2% +$5M
$17M
Cost of Revenue
—
R&D↑+0.5% +$4K
$787K
SG&A↑+3.9% +$318K
$9M
D&A↓-5.3% -$2K
$36K
Operating Income↓-26.6% -$1M
$-6M
EBITDA↓-5.3% -$2K
$36K
Interest Expense↓-1487.5% -$119K
$-111K
Interest Income↑+0.0% +$0
$14K
Other Income/Expense↑+33.4% +$239K
$-476K
Pretax Income↓-17.2% -$977K
$-7M
Tax Provision
$0
Net Income↓-17.3% -$980K
$-7M
Operating Margin↓-34.8pts
-89.8%
Net Margin↓-32.2pts
-95.1%
Effective Tax Rate↓-0.0pts
-0.1%
ETR (Continuing Operations)↓-0.2pts
-0.3%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-4.5pts
-0.2%
ETR Foreign Differential (pp)↓-0.2pts
-0.1%
Operating Lease Cost↓-7.0% -$26K
$346K
Revenue YoY Variation↑+17.6pts
36.2%
Income YoY Variation↓-19.2pts
-26.6%
Revenue QoQ Variation↑+105.3pts
144.7%
Income QoQ Variation↓-25.8pts
-23.6%